Oncolytics Biotech Inc. (ONCY)
0.65
-0.01 (-1.63%)
At close: Mar 03, 2025, 3:59 PM
0.66
1.39%
After-hours: Mar 03, 2025, 04:00 PM EST
Oncolytics Biotech Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.85M | n/a | n/a | n/a | n/a | n/a | n/a | 783.46K | 699.76K | 313.31K | 208.87K | n/a | 310K | 1.00 |
| Cost of Revenue | 403K | 392K | 452.06K | 446.19K | 485.57K | 95.38K | 90.77K | 162.23K | 180.41K | n/a | n/a | 4.85M | 5.33M | 4.19M | 3.78M | 4.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | -403K | -392K | -452.06K | -446.19K | -485.57K | -95.38K | -90.77K | -162.23K | -180.41K | n/a | n/a | n/a | -5.33M | -4.19M | -3.78M | -4.31M | n/a | n/a | 783.46K | 699.76K | 313.31K | 208.87K | n/a | 310K | 1.00 |
| Operating Income | -33.79M | -28.57M | -26.23M | -25.46M | -20.69M | -16.66M | -15.61M | -15.29M | -13.92M | -18.82M | -23.9M | -36.69M | -28.72M | -20.04M | -17M | -18.07M | -16.85M | -15.5M | -12.53M | -12.63M | -6.62M | -6.75M | -7.14M | -4.65M | -577.37K |
| Interest Income | 1.33M | 528K | 98.61K | 121.19K | 179.28K | 173.5K | 130.1K | 163.9K | 197.86K | 210.39K | 371.49K | 345K | 416.25K | 76.93K | 30.83K | 519.26K | 1.21M | 1.23M | 783.46K | 699.76K | 313.31K | 208.87K | 655.21K | 905.69K | n/a |
| Pretax Income | -27.66M | -24.75M | -26.25M | -22.51M | -33.12M | -16.49M | -15.48M | -15.13M | -13.72M | -18.61M | -23.53M | -36.34M | -29M | -19.97M | -16.97M | -17.55M | -15.64M | -14.3M | -12.78M | -12.96M | -8.51M | -6.75M | -6.48M | -3.74M | n/a |
| Net Income | -27.75M | -24.84M | -26.3M | -19.55M | -45.55M | -17.04M | -15.62M | -15.14M | -13.72M | -18.62M | -23.53M | -36.37M | -29.04M | -19.97M | -17M | -17.55M | -15.64M | -14.3M | -12.78M | -12.96M | -8.54M | -6.09M | -6.17M | -3.61M | -574.46K |
| Selling & General & Admin | 16.08M | 11.49M | 12.86M | 12.07M | 8.84M | 7.08M | 6.21M | 5.36M | 5.14M | 5M | 372.74K | 730.75K | 1.14M | 3.25M | 4.4M | 64.04K | 4.53M | 4.03M | 3.15M | 5.47M | 2.95M | 2.1M | 1.56M | 1.06M | 89.03K |
| Research & Development | 17.71M | 15.43M | 12.92M | 12.94M | 11.13M | 9.42M | 9.39M | 9.77M | 8.6M | 13.82M | 18.51M | 31.4M | 23.39M | 12.19M | 12.15M | 13.35M | 11.32M | 10.54M | 9.31M | 7.11M | 3.31M | 4.28M | 5.12M | 3.69M | 486.66K |
| Other Expenses | n/a | n/a | 13.31M | 12.51M | 9.56M | 7.24M | 6.21M | 162.23K | 180.41K | 5M | 5.02M | 4.55M | n/a | 409.84K | 425.4K | 341.97K | 5.53M | 4.96M | 4M | 6.22M | 3.62M | 2.68M | 2.02M | 1.27M | 90.71K |
| Operating Expenses | 33.79M | 26.92M | 26.23M | 25.46M | 20.69M | 16.66M | 15.61M | 15.29M | 13.92M | 18.82M | 23.9M | 36.69M | 28.72M | 15.51M | 17M | 13.76M | 16.85M | 15.5M | 13.31M | 13.33M | 6.93M | 6.96M | 7.14M | 4.96M | 577.37K |
| Interest Expense | n/a | 528K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | -452.49K | -445.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 33.79M | 26.92M | 26.23M | 25.46M | 20.69M | 16.66M | 15.61M | 15.29M | 13.92M | 18.82M | 23.9M | 36.69M | 28.72M | 19.7M | 17M | 18.07M | 16.85M | 15.5M | 13.31M | 13.33M | 6.93M | 6.96M | 7.14M | 4.96M | 577.37K |
| Income Tax | 97K | 84K | 49.43K | -2.95M | 12.43M | 548.04K | 141.5K | 9.37K | 3.15K | 6.78K | 5.41K | 30.47K | 40K | 7.61K | 23.04K | n/a | -1.2M | -1.2M | -1.52K | 323.88K | 33.55K | -659.9K | -310.57K | -126.81K | -2.91K |
| Shares Outstanding (Basic) | 67.62M | 58.03M | 53.51M | 40.34M | 22.14M | 16.02M | 13.94M | 12.62M | 11.85M | 9.25M | 8.79M | 8.01M | 7.46M | 6.58M | 5.2M | 4.35M | 4.26M | 3.82M | 3.44M | 3.01M | 2.45M | 2.23M | 1.95M | 1.73M | 616.48K |
| Shares Outstanding (Diluted) | 67.62M | 58.03M | 53.51M | 40.34M | 22.14M | 16.02M | 13.94M | 12.62M | 11.85M | 9.25M | 8.79M | 8.01M | 7.46M | 6.58M | 5.2M | 4.35M | 4.26M | 3.82M | 3.44M | 3.01M | 2.45M | 2.23M | 1.95M | 1.83M | 616.48K |
| EPS (Basic) | -0.41 | -0.43 | -0.49 | -0.48 | -2.06 | -1.06 | -1.12 | -1.2 | -1.16 | -2.01 | -2.68 | -4.54 | -3.89 | -3.04 | -3.27 | -4.03 | -3.68 | -3.74 | -3.71 | -4.31 | -3.48 | -2.74 | -3.17 | -2.09 | -0.93 |
| EPS (Diluted) | -0.41 | -0.43 | -0.49 | -0.48 | -2.06 | -1.06 | -1.12 | -1.2 | -1.16 | -2.01 | -2.68 | -4.54 | -3.89 | -3.04 | -3.27 | -4.03 | -3.68 | -3.74 | -3.71 | -4.31 | -3.48 | -2.74 | -3.17 | -1.98 | -0.93 |
| EBITDA | -33.71M | -26.83M | -25.66M | -25.37M | -20.02M | -17.18M | -15.51M | -15.13M | -13.74M | -18.66M | -23.77M | -36.58M | -27.93M | -19.29M | -16.75M | -17.66M | -15.83M | -14.53M | -12.46M | -12.58M | -5.95M | -6.18M | -6.67M | -4.44M | -575.69K |
| Depreciation & Amortization | 81K | 392K | 452.06K | 446.19K | 485.57K | 95.38K | 90.77K | 162.23K | 180.41K | 163.5K | 131.62K | 109.28K | 92.59K | 63.16K | 257.25K | 410.25K | 1M | 926.68K | 855.99K | 751.75K | 663.52K | 574.24K | 465.45K | 205.2K | 1.68K |